On September 8, 2025, GSK plc bought back 219,116 shares at prices ranging from 1,446.00 to 1,485.50 pence each as part of its existing buyback program. Post-purchase, the company holds 245,945,676 shares in treasury and 4,069,456,051 shares issued.